Bridges Investment Counsel Trimmed Abbvie (ABBV) Stake By $2.73 Million; 11 Analysts Bullish Plains GP Holdings, L.P. (PAGP)

Among 27 analysts covering Plains GP Holdings LP (NYSE:PAGP), 11 have Buy rating, 0 Sell and 16 Hold. Therefore 41% are positive. Plains GP Holdings LP had 78 analyst reports since August 6, 2015 according to SRatingsIntel. Wells Fargo upgraded the stock to “Outperform” rating in Wednesday, October 5 report. The firm has “Neutral” rating given on Thursday, August 6 by Goldman Sachs. The rating was upgraded by Global Hunter Securities on Wednesday, September 9 to “Accumulate”. Stifel Nicolaus maintained the shares of PAGP in report on Friday, November 3 with “Hold” rating. Citigroup upgraded Plains GP Holdings, L.P. (NYSE:PAGP) rating on Friday, August 7. Citigroup has “Buy” rating and $21 target. The stock of Plains GP Holdings, L.P. (NYSE:PAGP) earned “Neutral” rating by Mizuho on Monday, January 30. The firm has “Neutral” rating by JP Morgan given on Wednesday, January 13. As per Friday, April 21, the company rating was downgraded by Jefferies. The firm earned “Buy” rating on Monday, August 28 by Raymond James. The firm earned “Hold” rating on Wednesday, January 13 by Stifel Nicolaus. See Plains GP Holdings, L.P. (NYSE:PAGP) latest ratings:

17/01/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Equal-Weight Downgrade
12/01/2018 Broker: Jefferies Rating: Buy New Target: $26.0 Maintain
05/01/2018 Broker: Credit Suisse Rating: Outperform New Target: $25 Initiates Coverage On
20/12/2017 Broker: Jefferies Rating: Buy New Target: $25.0 Maintain
16/11/2017 Broker: SunTrust Rating: Hold New Target: $24.0 Maintain
08/11/2017 Broker: Stifel Nicolaus Rating: Hold Old Target: $21 New Target: $22 Maintain
03/11/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $21.0 Maintain
17/10/2017 Broker: BMO Capital Markets Rating: Buy New Target: $25.0 Maintain
16/10/2017 Broker: Jefferies Rating: Buy New Target: $24.0 Maintain
12/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $20.0 Maintain

Bridges Investment Counsel Inc decreased Abbvie Inc (ABBV) stake by 41.24% reported in 2017Q3 SEC filing. Bridges Investment Counsel Inc sold 30,997 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Bridges Investment Counsel Inc holds 44,164 shares with $3.92 million value, down from 75,161 last quarter. Abbvie Inc now has $165.73B valuation. The stock decreased 0.53% or $0.55 during the last trading session, reaching $103.81. About 6.37M shares traded or 24.22% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 19, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

The stock decreased 2.28% or $0.53 during the last trading session, reaching $22.73. About 1.77 million shares traded or 2.20% up from the average. Plains GP Holdings, L.P. (NYSE:PAGP) has risen 3.32% since January 19, 2017 and is uptrending. It has underperformed by 13.38% the S&P500.

Plains GP Holdings, L.P. owns and operates midstream energy infrastructure in the United States and Canada. The company has market cap of $12.59 billion. It operates through three divisions: Transportation, Facilities, and Supply and Logistics. It currently has negative earnings. The Transportation segment engages in the transportation of crude oil and NGL on pipelines, gathering systems, trucks, and barges.

Investors sentiment increased to 1 in Q3 2017. Its up 0.67, from 0.33 in 2017Q2. It is positive, as 0 investors sold Plains GP Holdings, L.P. shares while 1 reduced holdings. 0 funds opened positions while 1 raised stakes. 1.08 million shares or 6.78% more from 1.01 million shares in 2017Q2 were reported. Bush Odonnell Inv Advsr, Missouri-based fund reported 23,371 shares. Terril Brothers reported 1.06M shares stake.

Since July 31, 2017, it had 0 buys, and 8 insider sales for $45.57 million activity. SALEKI-GERHARDT AZITA sold $705,655 worth of AbbVie Inc. (NYSE:ABBV) on Monday, September 11. $1.66M worth of AbbVie Inc. (NYSE:ABBV) was sold by Gosebruch Henry O on Monday, October 30. Schumacher Laura J sold 145,510 shares worth $14.07M. Michael Robert A. also sold $589,512 worth of AbbVie Inc. (NYSE:ABBV) on Thursday, September 28. 87,040 shares valued at $8.57 million were sold by RICHMOND TIMOTHY J. on Monday, December 18. Another trade for 87,899 shares valued at $6.24 million was sold by GONZALEZ RICHARD A.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28 billion for 18.15 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc has $130.0 highest and $6 lowest target. $83.78’s average target is -19.29% below currents $103.81 stock price. Abbvie Inc had 71 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Outperform” rating by William Blair given on Friday, February 5. The stock of AbbVie Inc. (NYSE:ABBV) has “” rating given on Monday, September 28 by Citigroup. The stock has “Buy” rating by Jefferies on Friday, July 14. BMO Capital Markets maintained the stock with “Hold” rating in Friday, April 28 report. The rating was downgraded by Cowen & Co to “Market Perform” on Monday, June 6. The stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given on Thursday, January 4 by Jefferies. Cowen & Co upgraded AbbVie Inc. (NYSE:ABBV) on Wednesday, October 11 to “Outperform” rating. Piper Jaffray maintained the stock with “Buy” rating in Friday, September 15 report. The rating was maintained by Goldman Sachs with “Buy” on Friday, March 10. As per Friday, August 18, the company rating was maintained by Jefferies.

Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.15, from 1 in 2017Q2. It is negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Carroll Associate Incorporated reported 6,058 shares stake. Beaumont Fincl Ptnrs Ltd Liability Com owns 5,630 shares for 0.06% of their portfolio. Oakworth Capital Inc accumulated 11,771 shares. Amica Retiree Medical Tru accumulated 0.68% or 9,640 shares. Markston Intll Lc, New York-based fund reported 152,684 shares. 34,363 are owned by Benjamin F Edwards And Inc. Jasper Ridge Partners LP has invested 0.04% in AbbVie Inc. (NYSE:ABBV). Clean Yield Group Incorporated accumulated 9,583 shares. Schulhoff & stated it has 1.26% of its portfolio in AbbVie Inc. (NYSE:ABBV). Pennsylvania holds 261,041 shares or 1.12% of its portfolio. Donaldson Cap Mgmt Limited Liability stated it has 417,872 shares. Princeton Port Strategies Group Incorporated Limited Liability Company has invested 2.71% of its portfolio in AbbVie Inc. (NYSE:ABBV). Shine Invest Advisory Service stated it has 500 shares or 0.02% of all its holdings. Monetary has invested 1.6% of its portfolio in AbbVie Inc. (NYSE:ABBV). Moreover, Drexel Morgan And has 0.48% invested in AbbVie Inc. (NYSE:ABBV) for 5,300 shares.